You have 9 free searches left this month | for more free features.

lymphoproliferative disorder

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Schizophrenia, Relatives Trial in Creteil (Clinical and environmental evaluation)

Unknown status
  • Patients With Schizophrenia
  • Relatives
  • Clinical and environmental evaluation
  • Creteil, France
    Henri Mondor Hospital
Sep 27, 2017

MDD, Generalized Anxiety Disorder Trial in Cleveland (Quetiapine XR, Placebo)

Terminated
  • Major Depressive Disorder
  • Generalized Anxiety Disorder
  • Quetiapine XR
  • Placebo
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Nov 9, 2016

CD180 Overexpression in Follicular Lymphoma

Completed
  • Follicular Lymphoma
    • (no location specified)
    Nov 29, 2016

    Depressive Disorder, Anxiety Disorder Trial in Germany, United States (Vortioxetine)

    Completed
    • Depressive Disorder
    • Anxiety Disorder
    • Washington, District of Columbia
    • +6 more
    Feb 8, 2017

    Disorder Post Traumatic Stress After Attacks in Paris In

    Unknown status
    • Stress Disorders, Post-Traumatic
      • (no location specified)
      Jun 22, 2017

      Bipolar Disorder Trial in Baltimore (Valacyclovir, Placebo)

      Completed
      • Bipolar Disorder
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine, Dept. of Psychiatry
      Feb 28, 2017

      Fatty Liver Disease, Nonalcoholic, Nonalcoholic Steatohepatitis, Lipodystrophy Trial in Ann Arbor (Metreleptin)

      Completed
      • Fatty Liver Disease, Nonalcoholic
      • +2 more
      • Ann Arbor, Michigan
        University of Michigan
      May 11, 2017

      Familial Hypercholesterolemia Trial in Taipei

      Unknown status
      • Familial Hypercholesterolemia
        • Taipei, Taiwan
          NTUH
        May 11, 2017

        MDD Trial in Boston (Ketamine)

        Completed
        • Major Depressive Disorder
        • Boston, Massachusetts
          Depression Clinical and Research Program - MGH
        Apr 18, 2017

        Mental Disorders, Domestic Violence Trial in Tehran (Narrative Exposure Therapy, Treatment-as-usual)

        Completed
        • Mental Disorders
        • Domestic Violence
        • Narrative Exposure Therapy
        • Treatment-as-usual
        • Tehran, Iran, Islamic Republic of
          Mental Health Clinics
        Apr 24, 2017

        Bipolar Disorder Trial in Chicago

        Completed
        • Bipolar Disorder
          • Chicago, Illinois
            Northwestern University
          Mar 26, 2017

          Autism Spectrum Disorder Trial in Seattle (Assessment, Monitoring & Intervention)

          Completed
          • Autism Spectrum Disorder
          • Assessment, Monitoring & Intervention
          • Seattle, Washington
            Center on Human Development and Disabilities, University of Wash
          Apr 18, 2017

          New Variants Involved in Taybi-Linder Syndrome

          Unknown status
          • Taybi Linder Syndrome
          • Genetic Syndrome
          • Deoxyribonucleic acid analysis
          • Lyon, France
            Service de Génétique Clinique, Groupement Hospitalier Est, Hospi
          Jul 18, 2017

          Conduct Disorder in Prison: Search for Prospective and

          Completed
          • Mental Disorders
          • Antisocial personality recording of behavior and contextual elements
          • Rochefort, France
            Maison d'arrêt de Rochefort
          Mar 3, 2017

          Alcohol Dependence Trial in Tampa (Motivational Enhancement Therapy)

          Completed
          • Alcohol Dependence
          • Motivational Enhancement Therapy
          • Tampa, Florida
            University of South Florida
          May 16, 2017

          PTSD (PTSD) Trial in Boston (Medication augmentation, CBT)

          Terminated
          • Posttraumatic Stress Disorder (PTSD)
          • Medication augmentation
          • CBT
          • Boston, Massachusetts
            Massachusetts General Hospital
          Apr 10, 2017

          Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks

          Completed
          • Drug Use Disorders
          • +6 more
            • (no location specified)
            Oct 11, 2017

            Active Rheumatoid Arthritis Trial (Topical compound tripterygium, Placebo)

            Completed
            • Active Rheumatoid Arthritis
            • Topical compound tripterygium
            • Placebo
            • (no location specified)
            Apr 27, 2017

            Schizotypal Personality Disorder, Personality Disorders Trial in New York (Guanfacine, Placebo)

            Terminated
            • Schizotypal Personality Disorder
            • Personality Disorders
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Feb 9, 2017

            Determine Sensitivity and Specificity of 2 Non-invasive Markers

            Terminated
            • Coronary Artery Disease
              • Montreal, Quebec, Canada
                Royal Victoria Hospital
              Apr 5, 2017

              Non-erosive Gastroesophageal Reflux Disease, Functional Dyspepsia, Irritable Bowel Syndrome Trial in Hong Kong (Counseling)

              Completed
              • Non-erosive Gastroesophageal Reflux Disease
              • +2 more
              • Counseling
              • Hong Kong, Hong Kong
                Prince of Wales Hospital
              Apr 25, 2017

              MDD Trial in Belmont (Lisdexamfetamine Dimesylate (Vyvanse), Placebo)

              Completed
              • Major Depressive Disorder
              • Lisdexamfetamine Dimesylate (Vyvanse)
              • Placebo
              • Belmont, Massachusetts
                McLean Hospital
              Apr 19, 2017

              Susceptibility to Thrombosis in Pseudotumor Cerebri of

              Completed
              • Pseudotumor Cerebri
              • Cystinosis
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center, 9000 Rockville Pi
                Jun 30, 2017

                An fMRI Study on Temporal Discounting in Bipolar Disorder

                Completed
                • Bipolar Disorder
                • +2 more
                • fMRI Scanning
                • Boston, Massachusetts
                  Bipolar Clinic and Research Program at Massachusetts General Hos
                Feb 8, 2017